I have been very actively researching Dimebon in clinical research studies under strict FDA and industry guidelines, and saw the below article and felt my readers would be most interested in learning more about an “outsider” looking in at the potential for this drug if FDA approved for Alzheimer’s Disease.
For the Treatment of Alzheimer’s Disease, [...]
The Memory Enhancement Centers of America are very proud to have added the Toms River NJ site headed by Dr. Sanjiv Sharma, MD (board certified fellowship trained geriatrician) and the Memory Enhancement Center of Brooklyn, headed by Dr. Jeffrey Ben-Zvi, MD (board certified in geriatric medicine).
These two centers of excellence will now provide even more [...]
Iberica USA has announced that its new 28 bed inpatient facility is officially open effective January 18, 2008. Iberica’s Clinical Research Center (ICRC) will bring a new level of high quality phase I/IIA research to the pharmaceutical world.
It “home like” environment, 20 single rooms and 4 double bedded rooms, staffed with the most caring and [...]
Dr. Ross radio interview - on WOBM-AM - Bob and Marianne [12:07m]: Play Now | Play in Popup | Download Want to know the newest ways to treat AD?
Elan progresses two of its Alzheimer’s compounds with partners
Elan and Transition Therapeutics have started a Phase II trial of the potential Alzheimer’s disease compound they are jointly developing, ELND005 (formerly AZD-103).
ELND005 is an orally administered product that was shown in animal models to act by preventing and [...]